September 5, 2003
“Defining the Role of Transforming Growth Factor Beta-1 in Atherogenesis”
Andrew Frutkin, MD, Cardiology Fellow, Division of Cardiology, University of
Washington
September 12, 2003
“CHARM (Candesartan in Heart Failure Assessment of Reduction
in Mortality and Morbidity):
Final Results”, Jeffrey Probstfield, MD, Professor, Division of
Cardiology, University of Washington
September 19, 2003
“Pharmacological Control of Intimal Hyperplasia and Restenosis“
Alexander W. Clowes, MD, Professor and Chief, Division of Vascular Surgery,
Department of Surgery, University of Washington .
September 26, 2003
“The Genetic Hypertriglyceridemias and Premature Coronary Disease: The Metabolic Syndrome”
John Brunzell, MD, Professor, Division of Metabolism, Endocrinology &
Nutrition; Director, General Clinical Research Center, University of Washington
October 3, 2003
“Cardiology Pathology Autopsy Case Conference”
Corinne Fligner, MD, Associate Professor, Department of Pathology, Director,
Autopsy Service, University of Washington Medical Center
October 10, 2003
“Sympathetic Dysfunction in Congestive Heart Failure”
James Caldwell, Jr., MD, Professor, Division of Cardiology, University of
Washington
October 17, 2003
“Chlamydia Pneumoniae and Cardiovascular Disease: Strength of the Association”
Michael E. Rosenfeld, PhD, Professor, Pathobiology, School of Public Health
& Community Medicine, University of Washington
October 24, 2003
“The Role of Oral Antithrombotic Therapy in the Prevention of Myocardial
Infarctions – A Common Clinical Controversy”
Steven L. Goldberg, MD, Associate Professor, Division of Cardiology, University
of Washington
October 31, 2003
“The Cardio Renal Anemia Syndrome – The Vicious Circle of Heart Failure, Renal
Failure and Anemia”
Donald Silverberg, MD, FRCP (Canada), Professor of Medicine, University of Tel
Aviv, Israel
November 14, 2003
“Metabolic Syndrome and the Unstable Atherosclerotic Plaque”
Alberto Zambon, MD, PhD, Assistant Professor of Medicine, Department of Medical
and Surgical Sciences, University of Padua, Padua, Italy
November 21, 2003
“Altering the Course of Coronary Artery Disease: Plaque Regression as a Goal of Therapy”
David Linker, MD, Associate Professor, Division of Cardiology, University of
Washington
December 5, 2003
“The Metabolic Syndrome: The Most
Prevalent Risk for Coronary Heart Disease?” Robert H. Eckel, MD, Charles A.
Boettcher Endowed Chair in Atherosclerosis, Professor of Medicine, and of
Physiology and Biophysics, Program Director, Adult GCRC, University of
Colorado, Denver, Colorado
December 12, 2003
“50 Years of Echocardiography. Doppler
Echo: Better than Catheter”
Catherine M. Otto, MD, Professor, Division of Cardiology, University of
Washington
December 19, 2003
“PAD Trial (Public Access Defibrillation)”
Alfred P. Hallstrom, PhD, Professor of Biostatistics, University of Washington
January 9, 2004
“BNP – The Level and the Drug: Partners
in the Diagnosis and Management of Heart Failure”
Alan S. Maisel, MD, Professor of Medicine, University of California, San Diego,
Director, Coronary Care Unit and Heart Failure Program, Veterans Affairs
Medical Center, San Diego, California
January 16, 2004
“Microalbuminuria: The Kidney’s Message
About The Systemic Vasculature”
Katherine R. Tuttle, MD, FACP, Director of Research, Department of Research,
The Heart Institute of Spokane, Spokane, WA,
Professor of Basic Medical Sciences, WAMI Program, Washington State
University, Spokane and Pullman, Washington
January 23, 2004
“Cardiovascular Effects of Sleep Apnea”
Jeanne Vesey, MD, Fellow, Division of Cardiology, University of Washington
School of Medicine
January 30, 2004
“Cardiology Pathology Autopsy Case Conference”
Corinne Fligner, MD, Associate Professor, Department of Pathology, University
of Washington School of Medicine, Director, Autopsy Service, University of
Washington Medical Center
February 6, 2004
‘Drug-Eluting Stents: Clinical Trials
and Status of the “Real World” Registries’
Elizabeth Gauer, MD, Fellow, Division of Cardiology University of Washington
School of Medicine
February 13, 2004
“Guidelines Implementation in Acute Coronary Syndromes: Does It Really Matter?”
Ralph Brindis, MD, MPH, FACC, Clinical Professor of Medicine, University of
California, San Francisco, and Regional Senior Advisor for Cardiovascular
Diseases, Northern California Kaiser Permanente, San Francisco, California
February 20, 2004
“Prediction of Death in Heart Failure – Seattle Heart Failure Score”
Wayne C. Levy, MD, Associate Professor, Division of Cardiology, University of
Washington
February 27, 2004
“Understanding and Treating Heart Failure as a Progressive Disease Syndrome”
William T. Abraham, MD, FACP, FACC, Professor of Internal Medicine, Adjunct
Professor of Physiology and Cell Biology and Chief, Division of Cardiovascular
Medicine, The Ohio State University Heart Center, Columbus, Ohio
March 5, 2004
“Gender Differences in Heart Disease”
Kiyon Chung, MD, Fellow, Division of Cardiology University of Washington School
of Medicine
March 12, 2004
“The Newest Therapies in Hyperlipidemia Management”
Robert H. Knopp, MD, Director, Northwest Lipid Research Clinic, Professor of
Medicine, University of Washington and Chief, Division of Metabolism,
Endocrinology & Nutrition, Harborview Medical Center
March 19, 2004
“Renal Failure and Coronary Artery Disease”, Gretchen Crittenden, MD, Fellow,
Division of Cardiology, University of Washington
March 26, 2004
“Primary Prevention of SCD: The Sudden
Cardiac Death-Heart Failure Trial”
Jeanne E. Poole, MD, Associate Professor of Medicine, Acting Director,
Arrhythmia Service and Daniel P. Fishbein, MD, Associate Professor of Medicine,
Director, Congestive Heart Failure and Transplant, Division of Cardiology,
University of Washington School of Medicine
April 2, 2004
“Calcium Scoring and Cardiovascular Disease”, Ramin Tabibiazar, MD, Fellow,
Division of Cardiology University of Washington School of Medicine
April 9, 2004
“Non-Glycemic Effects of Insulin: The
Rational of the ORIGIN Trial”
Irl B. Hirsch, MD, Professor of Medicine, University of Washington
April 16, 2004
“Myxomatous Mitral Valve Disease”
Kara Urnes, MD, Fellow, Division of Cardiology, University of Washington
April 23, 2004
“Cardiology Pathology Autopsy Case Conference”
Corinne Fligner, MD, Associate Professor of Pathology, Director, Autopsy
Service, University of Washington Medical Center
April 30, 2004
“Reduction in Acute Myocardial Infarctions After the Passage of a Comprehensive
Smokefree Ordinance”
Richard P. Sargent, MD, Family Health Clinic of Helena, St. Peter’s Hospital,
Helena, Montana
May 14, 2004
“Improving Guideline Adherence in Cardiovascular Disease”
Brian Keeffe, MD, Fellow, Division of Cardiology, University of Washington
May 21, 2004
“The Third Dimension in Imaging and Beyond”
Florence Sheehan, MD, Research Professor, Division of Cardiology, University of
Washington
May 28, 2004
“Inflammation and Cardiovascular Disease from the Surgical Perspective”, Edward
D. Verrier, MD, Professor and Chief, Cardiothoracic Surgery Division,
University of Washington
June 4, 2004
“The Effects of Omega-3 Fatty Acids on Cardiovascular Health”
Pathmaja (Bobbie) Paramsothy, MD, Fellow, Division of Cardiology, University of
Washington
June 11, 2004
“HRV as a Risk Stratifier Post Myocardial Infarction”
Robert Kleiger, MD, Professor of
Medicine, Cardiovascular Division, Washington University School of Medicine,
St. Louis, Missouri
June 18, 2004
“Insights and Clinical Implications of Recent Clinical Trials in Heart Failure”
Barry Greenberg, MD, Professor of Medicine and Director, Heart Failure/Cardiac
Transplantation Program, University of California, San Diego, California
June 25, 2004
Murray Visiting Professorship
‘PAI-1 and Cardiovascular Disease:
Mechanistic Insights for a “Super-Sized” Society’
Douglas E. Vaughan, MD, Professor of Medicine and Pharmacology, Division of
Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville,
Tennessee